Skip to main content
. 2020 Mar 4;368:m283. doi: 10.1136/bmj.m283

Table 1.

Characteristics of patients by status of opioid treatment in fiscal year 2013

Characteristics of patients Stopped opioid treatment Continued opioid treatment
No (%) of patients 799 668 (57.4) 594 434 (42.6)
Mean (SD) age (years) 59.8 (15.4; 5 missing) 61.3 (12.6; 6 missing)
No (%) of women 70 299 (8.8) 42 691 (7.2)
No (%) currently married 384 211 (48.0) 300 073 (50.5)
Residence location:
 No (%) in urban areas 515 452 (64.5) 344 722 (58.0)
 No (%) in rural areas 284 216 (35.5) 249 712 (42.0)
Mean (SD) No of medical diagnoses 2.9 (2.3) 3.1 (2.2)
No (%) of patients with 0 to ≥5 medical diagnoses:
 0 109 958 (13.8) 51 935 (8.7)
 1 139 174 (17.4) 97 395 (16.4)
 2 149 358 (18.7) 116 378 (19.6)
 3 130 677 (16.3) 106 613 (17.9)
 4 98 644 (12.3) 81 674 (13.7)
 ≥5 171 857 (21.5) 140 439 (23.6)
No (%) diagnosed with substance use disorders: 116 830 (14.6) 82 006 (13.8)
 Nicotine 165 993 (20.8) 145 973 (24.6)
 Alcohol 85 205 (10.7) 56 322 (9.5)
 Drug 66 282 (8.3) 46 102 (7.8)
 Cannabis 25 467 (3.2) 14 697 (2.5)
 Opioid 16 213 (2.0) 13 177 (2.2)
 Barbiturate 3,276 (0.4) 2,112 (0.4)
No (%) of patients with mental health diagnoses: 343 478 (42.9) 289 636 (48.7)
 Affective disorders 29 049 (3.6) 22 898 (3.8)
 Schizophrenia 15 637 (2.0) 10 242 (1.7)
 Post-traumatic stress disorder 144 758 (18.1) 121 388 (20.4)
 Major depressive disorder) 78 066 (9.8) 70 570 (11.9)
 Other depressive disorders 185 654 (23.2) 159 747 (26.9)
 General anxiety disorder 20 773 (2.6) 18 631 (3.1)
 Anxiety otherwise unspecified 81 315 (10.2) 67 058 (11.3)
 Other psychiatric diagnoses 12 912 (1.6) 8,548 (1.4)
Mean (SD) maximum daily morphine mg equivalents for opioid prescription 26.8 (35.0; 2 missing) 43.2 (66.1)
Opioid treatment type:
 No (%) long acting opioids 36 677 (4.6) 97 970 (16.5)
 No (%) short acting opioids 560 364 (70.1) 386 743 (65.0)
 No (%) tramadol only 202 627 (25.3) 109 721 (18.5)

SD=standard deviation.